ASK REDCHAT ANYTHING ABOUT ARBUTUS BIOPHARMA CORPORATION
Arbutus Biopharma Corporation (NASDAQ: ABUS)
Listen to this Section
$4.28
-0.0750
(
-1.72% )
296.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Imdusiran +NA therapy +VTP-300DetailsHepatitis B |
Phase 2a |
| Imdusiran +NA therapy +IFNDetailsHepatitis B |
Phase 2a |
| AB-101DetailsHepatitis B |
Phase 1 |
| AB-836 (capsid inhibitor)DetailsHepatitis B |
Failed |
| Imdusiran + NA therapy + low dose durvalumabDetailsHepatitis B |
Failed |
| AB-161 (Oral RNA destabilizer)DetailsHepatitis B |
Failed |
Market Data
|
| Open |
$4.28 |
| Previous Close |
$4.35 |
| Volume |
296.0K |
| Market Cap |
$859.29M |
| Day Range |
$4.26 - $4.37 |
| 52 Week Range |
$3.04 - $5.10 |
| Shares Outstanding |
197.54M |
| Change % |
-1.72% |
| Net Change |
▼ -0.0750 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2007 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-943,900.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-05-24 |
Sale |
-67000.00 |
BURGESS DANIEL D |
| 2024-05-24 |
Sale |
-67000.00 |
MANCHESTER KEITH S |
| 2024-05-24 |
Sale |
-67000.00 |
HENRIQUES RICHARD C JR |
| 2024-05-24 |
Sale |
-67000.00 |
Meyers James R |
| 2024-05-24 |
Sale |
-67000.00 |
Rewolinski Melissa |
| 2024-05-24 |
Sale |
-67000.00 |
Torti Frank |
| 2024-02-05 |
Sale |
-95100.00 |
Naftzger J. Christopher |
| 2024-02-05 |
Sale |
-101000.00 |
Sims Karen |
| 2024-02-05 |
Sale |
-112500.00 |
HASTINGS DAVID C |
| 2024-02-05 |
Sale |
-109500.00 |
Sofia Michael J. |